"Sarcopenia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles.
| Descriptor ID |
D055948
|
| MeSH Number(s) |
C10.597.613.612.500 C23.300.070.500.500 C23.888.592.608.612.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sarcopenia".
Below are MeSH descriptors whose meaning is more specific than "Sarcopenia".
This graph shows the total number of publications written about "Sarcopenia" by people in this website by year, and whether "Sarcopenia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sarcopenia" by people in Profiles.
-
Garber AK, Bennett JP, Wong MC, Tian IY, Maskarinec G, Kennedy SF, McCarthy C, Kelly NN, Liu YE, Machen VI, Heymsfield SB, Shepherd JA. Cross-sectional assessment of body composition and detection of malnutrition risk in participants with low body mass index and eating disorders using 3D optical surface scans. Am J Clin Nutr. 2023 10; 118(4):812-821.
-
Makrogiannis S. Editorial for "Diagnosis of Sarcopenia Using the L3 Skeletal Muscle Index Estimated from the L1 Skeletal Muscle Index on MR Images in Patients With Cirrhosis". J Magn Reson Imaging. 2023 11; 58(5):1579.
-
Du Y, Xu T, Yin Z, Espinoza S, Xie Y, Gentry C, Tian Q, Zhao LJ, Shen H, Luo Z, Deng HW. Associations of physical activity with sarcopenia and sarcopenic obesity in middle-aged and older adults: the Louisiana osteoporosis study. BMC Public Health. 2022 05 05; 22(1):896.
-
Staley SA, Tucker K, Newton M, Ertel M, Oldan J, Doherty I, West L, Zhang Y, Gehrig PA. Sarcopenia as a predictor of survival and chemotoxicity in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapy. Gynecol Oncol. 2020 03; 156(3):695-700.
-
Galan A, Rousset P, Mercier F, K?p?n?kian V, Valette PJ, Glehen O, Passot G. Overall survival of pseudomyxoma peritonei and peritoneal mesothelioma patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy can be predicted by computed tomography quantified sarcopenia. Eur J Surg Oncol. 2018 11; 44(11):1818-1823.
-
Sanada K, Chen R, Willcox B, Ohara T, Wen A, Takenaka C, Masaki K. Association of sarcopenic obesity predicted by anthropometric measurements and 24-y all-cause mortality in elderly men: The Kuakini Honolulu Heart Program. Nutrition. 2018 02; 46:97-102.
-
Sinha-Hikim I, Sinha-Hikim AP, Parveen M, Shen R, Goswami R, Tran P, Crum A, Norris KC. Long-term supplementation with a cystine-based antioxidant delays loss of muscle mass in aging. J Gerontol A Biol Sci Med Sci. 2013 Jul; 68(7):749-59.
-
Kovacheva EL, Hikim AP, Shen R, Sinha I, Sinha-Hikim I. Testosterone supplementation reverses sarcopenia in aging through regulation of myostatin, c-Jun NH2-terminal kinase, Notch, and Akt signaling pathways. Endocrinology. 2010 Feb; 151(2):628-38.